Skip to content

iRhythm Holdings, Inc. IRTC Gross Unrealized Gains

Gross Unrealized Gains at other companies

Medtronic logo
MedtronicMDT
Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$199.4M+25.7%
Gross profit$141.4M+29.4%
Operating income-$16.2M+50.3%
Net income-$13.9M+54.6%
EPS (diluted)-$0.43+55.7%

Balance sheet

See full
Cash & equivalents$248.5M-35.2%
Total debt$79.0M-10.5%
Total equity$161.2M+86.0%
Total assets$1.0B+8.7%

Cash flow

See full
Operating cash flow-$26.2M-232%
CapEx$6.9M-26.7%
Free cash flow-$33.1M-91.1%

Valuation

See full
Market cap$3.62B+16.0%

Profitability

See full
Gross margin71%+1.6pp
Operating margin-5.5%-2.2pp
Net margin-7.3%-3.1pp
FCF margin2.4%

Returns & leverage

See full
Return on equity-53.1%-17.4pp
Debt / equity0.5×-0.5×
Current ratio5.2×-0.5×

Where this comes from

Reported directly by iRhythm Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: iRhythm Holdings, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRhythm Holdings, Inc. 's gross unrealized gains.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRhythm Holdings, Inc. 's gross unrealized gains?
iRhythm Holdings, Inc. (IRTC) reported gross unrealized gains of $26K in Q1 2026.
How has iRhythm Holdings, Inc. 's gross unrealized gains changed year-over-year?
iRhythm Holdings, Inc. 's gross unrealized gains decreased by 48.0% year-over-year, from $50K to $26K.
What is the long-term trend for iRhythm Holdings, Inc. 's gross unrealized gains?
Over 5 years (2020 to 2025), iRhythm Holdings, Inc. 's gross unrealized gains has grown at a 73.7% compound annual growth rate (CAGR), from $18K to $285K.